跳至主要内容
临床试验/EUCTR2013-002511-99-IT
EUCTR2013-002511-99-IT进行中(未招募)1 期

Role of PET/ CT with 18F-fluorocholine in the staging of patients with intermediate/high risk prostate cancer.Phase III, randomized, open-label clinical trial

ISTITUTO ONCOLOGICO VENETO0 个研究点目标入组 390 人开始时间: 2013年10月16日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
390

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Histologically proven prostate cancer with Gleason score =7 and PSA>=10ng/ml or Gleason score >=8 and any PSA level or cT2-T3 and any PSA level or any Gleason score and PSA>=20ng/ml
  • Age more than 18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 290

排除标准

  • Metastatic disease
  • Patients treated with anti-androgen therapy or radiotherapy
  • Previous malignancy

研究者

相似试验